The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs

NCT00002368 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2000

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Nevirapine
DRUG: Lamivudine

Sponsor

Boehringer Ingelheim